Work

Azacitidine treatment for myeloid leukemia associated with Down syndrome: A nationwide retrospective study in Japan

Year: 2024

Type: article

Study design: Observational Study

Source: Pediatric Blood & Cancer

DOI: 10.1002/pbc.31244

Authors: Shota Kato, Kentaro Nakashima, Genki Yamato, Shoji Saito, Yuichi Taneyama, Nobuyuki Yamamoto, Takako Miyamura, Keisuke Kato, Yuya Sato, Ai Yamada, Takahiro Kamiya, Takuro Nishikawa, Suguru Uemura, Daisuke Tomizawa, Hiroshi Moritake, Kiminori Terui, Takashi Taga, Daisuke Hasegawa

Institutions: The University of Tokyo, Kyushu University, Gunma University, Shinshu University, Shinshu University Hospital, Chiba Children's Hospital, Kobe University, The University of Osaka, Ibaraki Children's Hospital, Dokkyo Medical University, University of Miyazaki, Tokyo Medical and Dental University, Kagoshima University, Kobe Children's Hospital, National Center For Child Health and Development, Hirosaki University, Shiga University of Medical Science, St. Luke's International Hospital

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science

Awards: G1771992781, ダウン症候群の一過性骨髄異常増殖症における新規治療法の開発を目指した基礎的検討, Prevention of cyclophosphamide induced myocardial damage by avoiding calcium ion dysregulation.., G8751291971

OpenAlex ID: W4401345720

FWCI: 0.866

Cites: 19

Cited by: 3

Related to: 10